These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22343256)

  • 1. Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Cross DM; Chmielewski G; Lewis EM; Liu L; Modesitt MS; Ripp SL; Sawaryn CM; Bowman CJ
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):29-39. PubMed ID: 22343256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Dowell JA; Schranz J; Baruch A; Foster G
    J Clin Pharmacol; 2005 Dec; 45(12):1373-82. PubMed ID: 16291712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Perkhofer S; Lass-Flörl C
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
    Crandon JL; Banevicius MA; Fang AF; Crownover PH; Knauft RF; Pope JS; Russomanno JH; Shore E; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5102-7. PubMed ID: 19770284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges.
    Bowman CJ; Chmielewski G; Lewis E; Ripp S; Sawaryn CM; Cross DM
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):333-44. PubMed ID: 21594975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
    van de Sande WW; Mathot RA; ten Kate MT; van Vianen W; Tavakol M; Rijnders BJ; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2009 May; 53(5):2005-13. PubMed ID: 19237647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Petraitis V; Petraitiene R; Hope WW; Meletiadis J; Mickiene D; Hughes JE; Cotton MP; Stergiopoulou T; Kasai M; Francesconi A; Schaufele RL; Sein T; Avila NA; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2382-91. PubMed ID: 19307368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
    Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN
    Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
    Verlindo de Araujo B; Farias da Silva C; Costa TD
    Pharmacology; 2010; 86(3):163-7. PubMed ID: 20714206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
    Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
    Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Lazarus HM; Blumer JL; Yanovich S; Schlamm H; Romero A
    J Clin Pharmacol; 2002 Apr; 42(4):395-402. PubMed ID: 11936564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
    Walsh TJ; Karlsson MO; Driscoll T; Arguedas AG; Adamson P; Saez-Llorens X; Vora AJ; Arrieta AC; Blumer J; Lutsar I; Milligan P; Wood N
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2166-72. PubMed ID: 15155217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
    Chan HM; Duran SH; Walz PH; Ravis WR
    J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
    Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
    Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
    Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
    Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
    Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Rüping MJ; Müller C; Vehreschild JJ; Böhme A; Mousset S; Harnischmacher U; Frommolt P; Wassmer G; Drzisga I; Hallek M; Cornely OA
    Mycoses; 2011 May; 54(3):230-3. PubMed ID: 19889174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.